Axsome Therapeutics, Inc.
AXSM
33 insider filings · Latest: Jul 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 1 8:05 PM | Coleman Mark | Proposed Sale | 6,000 | $230.30 | $1.4M | — | View → |
| May 29, 2026 | May 29 8:09 PM | Coleman Mark | Proposed Sale | 6,000 | $233.46 | $1.4M | — | View → |
| May 5, 2026 | May 6 12:34 AM | Mark L. JacobsonChief Operating Officer | Sale | 233 | $228.18 | $53.2K | 0(D) | View → |
| May 4, 2026 | May 6 12:34 AM | Mark L. JacobsonChief Operating Officer | Sale | 4,517 | $227.94 | $1.0M | 0(D) | View → |
| May 5, 2026 | May 5 9:55 PM | Mark Jacobson | Proposed Sale | 233 | $223.06 | $52.0K | — | View → |
| May 4, 2026 | May 5 9:54 PM | Mark Jacobson | Proposed Sale | 4,517 | $223.70 | $1.0M | — | View → |
| May 4, 2026 | May 4 9:43 PM | Mark Jacobson | Proposed Sale | 4,517 | $223.70 | $1.0M | — | View → |
| Apr 22, 2026 | Apr 24 1:01 AM | Ari MaizelChief Commercial Officer | Sale | 7,500 | $182.42 | $1.4M | 0(D) | View → |
| Apr 22, 2026 | Apr 22 8:03 PM | Maizel Ari | Proposed Sale | 7,500 | $182.42 | $1.4M | — | View → |
| Feb 26, 2026 | Feb 28 12:00 AM | Mark ColemanDirector | Sale | 25,000 | $161.11 | $4.0M | 47,140(D) | View → |
| Feb 26, 2026 | Feb 28 12:00 AM | Mark L. JacobsonChief Operating Officer | Sale | 35,378 | $161.88 | $5.7M | 0(D) | View → |
| Feb 26, 2026 | Feb 26 9:53 PM | Mark Jacobson | Proposed Sale | 35,378 | $163.19 | $5.8M | — | View → |
| Feb 26, 2026 | Feb 26 9:20 PM | Coleman Mark | Proposed Sale | 25,000 | $161.11 | $4.0M | — | View → |
| Feb 2, 2026 | Feb 2 11:30 PM | TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner | Sale | 32,410 | $185.60 | $6.0M | 7,229(D) | View → |
| Feb 2, 2026 | Feb 2 10:30 PM | Herriot Tabuteau | Proposed Sale | 32,410 | $185.88 | $6.0M | — | View → |
| Jan 22, 2026 | Jan 24 12:00 AM | Nick PizzieChief Financial Officer | Sale | 12,000 | $187.92 | $2.3M | 42,588(D) | View → |
| Jan 21, 2026 | Jan 24 12:00 AM | Ari MaizelChief Commercial Officer | Sale | 7,500 | $184.44 | $1.4M | 0(D) | View → |
| Jan 22, 2026 | Jan 22 9:02 PM | Pizzie Nick | Proposed Sale | 12,000 | $187.92 | $2.3M | — | View → |
| Jan 21, 2026 | Jan 21 9:08 PM | Maizel Ari | Proposed Sale | 7,500 | $184.44 | $1.4M | — | View → |
| Jan 7, 2026 | Jan 7 9:44 PM | Herriot Tabuteau | Proposed Sale | 31,261 | $170.69 | $5.3M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Feb 28 12:10 AM | Nick PizzieChief Financial Officer | Grant/Award | 18,570 | — | 18,570(D) | View → |
| Feb 26, 2026 | Feb 28 12:10 AM | Hunter R. MurdockGeneral Counsel | Grant/Award | 16,385 | — | 16,385(D) | View → |
| Feb 26, 2026 | Feb 28 12:10 AM | Ari MaizelChief Commercial Officer | Grant/Award | 16,385 | — | 16,385(D) | View → |
| Feb 26, 2026 | Feb 28 12:10 AM | Mark L. JacobsonChief Operating Officer | Grant/Award | 19,663 | — | 19,663(D) | View → |
| Feb 26, 2026 | Feb 28 12:00 AM | Mark L. JacobsonChief Operating Officer | Option Exercise | 35,378 | $2.85 | 0(D) | View → |
| Feb 23, 2026 | Feb 26 12:00 AM | Mark ColemanDirector | Option Exercise | 6,250 | $4.95 | 7,721(D) | View → |
| Feb 20, 2026 | Feb 24 12:23 AM | Mark ColemanDirector | Option Exercise | 12,485 | $4.95 | 13,971(D) | View → |
| Feb 10, 2026 | Feb 11 12:11 AM | Mark ColemanDirector | Option Exercise | 5,193 | $8.02 | 0(D) | View → |
| Feb 2, 2026 | Feb 2 11:30 PM | TABUTEAU HERRIOTDirector, Chief Executive Officer, 10% Owner | Option Exercise | 32,410 | $185.60 | 0(D) | View → |
| Jan 22, 2026 | Jan 24 12:00 AM | Nick PizzieChief Financial Officer | Option Exercise | 12,000 | $3.50 | 105,000(D) | View → |
| Jan 21, 2026 | Jan 24 12:00 AM | Ari MaizelChief Commercial Officer | Option Exercise | 7,500 | $70.73 | 31,210(D) | View → |
← Previous
Page 2 of 2